COVID-19
| 2 min read
As the science on vaccination and natural infection-based immunity against COVID-19 variants continues to evolve, accurately communicating study results and their limitations has never been more important.
Available on Demand
LIVE April 19th, 2022 at 11:30 AM
Biologics targeting coronavirus and variants of interest emerge as the latest therapeutic strategy for treating COVID-19.
Biologics targeting coronavirus and variants of interest emerge as the latest therapeutic strategy for treating COVID-19.
| 8 min read
After tragedy struck during a 1960s clinical trial, development of a vaccine for RSV ground to a halt. But as new RSV vaccine candidates enter late-stage clinical trials, a safe and effective vaccine is finally in sight.
| 2 min read
Just as the delta outbreak subsided, the omicron outbreak peaked. How will we navigate this new pandemic terrain?
| 10+ min read
As reports of disrupted menstrual cycles after COVID-19 vaccinations rose, researchers investigated the connection. Their reports revealed that while vaccine-associated menstrual changes may be small and temporary, knowledge of these potential side effects is vital for public trust.
| 6 min read
Red blood cells may play a role in COVID-19 and other infections.
| 2 min read
From tuberculosis to drug-resistant bacterial infections, infectious diseases that plagued the globe long before COVID-19 still affect people today.
| 3 min read
People with cystic fibrosis seem resistant to COVID-19. Researchers developed a culture system to interrogate the mechanism behind it.
| 5 min read
A bioengineer mines the biometric data from smartwatches and smartphones to find digital biomarkers for respiratory infections like COVID-19.
| 4 min read
Researchers use GWAS to understand why some people lose their sense of smell and taste when they are infected with COVID-19.
